Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
Hong Zhou of Arkansas State University has received an Arkansas Science & Technology Authority grant of $43,374 to fund his research into early detection and prevention of skin cancer.
Bentonville finds itself in the Advertising Age spotlight Tuesday. Ad Age has a look at how Bentonville -- aka Vendorville -- and the region have been transformed by the growth of Wal-Mart and its cache of vendors on the ground in northwest Arkansas.
Europe's increasing emphasis on renewable energy lies behind the announcements this summer that two companies plan to build wood pellet plants in Arkansas.
For close to 40 years now, mentoring in the workplace has been examined extensively in hundreds of peer-reviewed studies. The results of these studies demonstrate many benefits to the career success of the protege, the career of the mentor and the organizations that encourage informal mentoring or have developed formal mentoring programs.